Overview

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.
Phase:
Phase 3
Details
Lead Sponsor:
Guerbet
Treatments:
Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate